Development of an innovative adult attention-deficit hyperactivity disorder clinic

Abstract

Pharmacist-psychiatrist collaborative clinic models in specialty mental health clinics are limited, and there has been only 1 report of a clinic focused on adult attention-deficit hyperactivity disorder (ADHD). In this article, we describe the successful implementation of a pharmacist-psychiatrist collaborative practice agreement in an adult ADHD clinic at an academic medical center. Adult patients diagnosed with ADHD after a comprehensive assessment, including a full neuropsychological evaluation, were enrolled in the collaborative treatment clinic. The collaboration was a partnership between a psychiatry department and a school of pharmacy at a public university. We report the details of 58 patients and 774 patient encounters at the collaborative pharmacist-psychiatrist practice from March 2015 through June 2018. The visits were billed using traditional medical billing codes for follow-up visits. Pharmacist practice opportunities included psychiatric evaluation, medication management, counseling, and referral to auxiliary services. Challenges to the clinic's success included limited pharmacist time, prescriptive authority, and reimbursement for services from payors. A collaborative practice model targeted at adult ADHD patients may be a unique clinic setting for psychiatric pharmacists.

Role of Board‐Certified Psychiatric Pharmacists in child and adolescent psychiatry

“…34 Regulatory standards, including the Hospital Based Inpatient Psychiatric Services measure set, a collection of quality measures created by The Joint Commission, aims to standardize the quality of care patients receive in psychiatric care settings. 1,35 Board-Certified Psychiatric Pharmacists in CAP are well positioned to support these quality care initiatives given their roles in medication monitoring, deprescribing practices, medication safety, medication reconciliation, and psychotropic stewardship (Table 2). 1,4…”

“…36 (2) prescribed an antipsychotic for an off-label use in conjunction/ after appropriate psychosocial intervention(s), and (3) receiving annual metabolic monitoring. 35 F I G U R E 1 Board-Certified Psychiatric Pharmacist's (BCPP's) role in child and adolescent psychiatry interdisciplinary team.…”

Knowledge, Attitude, and Readiness of Pharmacists in Iraq toward Medication Therapy Management for Patients with Attention Deficit Hyperactivity Disorder: A Cross-sectional Study

“…A recent study described the successful implementation and partnership of a collaborative agreement between pharmacists and psychiatrists. Pharmacist involvement included psychiatric assessment, medication management, counseling, and referral to support service [17]. To provide accurate and up-to-date patient counseling, pharmacists must have an adequate understanding of the disease's state and its treatment.…”

Best practice model for outpatient psychiatric pharmacy practice, part 2: Confirmation of the attribute statements

“…Outpatient psychiatric pharmacists should be able to receive reimbursement for clinical services. 62 , 78 …”

“…Outpatient psychiatric pharmacists should be able to receive reimbursement for clinical services. 62 , 78 Outpatient psychiatric pharmacists should be able to bill third-party payers and receive reimbursement for clinical services like other healthcare professionals, to allow more patients to access pharmacist services. 27.…”